Your browser doesn't support javascript.
loading
Vimentin-positive invasive breast carcinoma of no special type: A breast carcinoma with lethal biological characteristics.
Ichinose, Yuki; Hasebe, Takahiro; Hirasaki, Masataka; Sakakibara, Ayaka; Yokogawa, Hideki; Nukui, Asami; Hiratsuka, Miyuki; Fujimoto, Akihiro; Iso, Chihiro; Wakui, Noriko; Shibasaki, Satomi; Kamada, Koichi; Suzuki, Nobuyuki; Kamakura, Yasuo; Yasuda, Masanori; Aya, Asano; Shimada, Hiroko; Matsuura, Kazuo; Ishiguro, Hiroshi; Osaki, Akihiko; Saeki, Toshiaki.
Affiliation
  • Ichinose Y; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Hasebe T; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Hirasaki M; Department of Clinical Cancer Genomics, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Sakakibara A; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Yokogawa H; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Nukui A; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Hiratsuka M; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Fujimoto A; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Iso C; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Wakui N; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Shibasaki S; Community Health Science Center, Saitama Medical University, Iruma, Saitama, Japan.
  • Kamada K; Department of Pathology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Suzuki N; Department of Pathology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Kamakura Y; Department of Clinical Cancer Genomics, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Yasuda M; Department of Pathology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Aya A; Department of Breast Oncology, Saitama Medical University, Iruma, Saitama, Japan.
  • Shimada H; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Matsuura K; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Ishiguro H; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Osaki A; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
  • Saeki T; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka City, Saitama, Japan.
Pathol Int ; 73(9): 413-433, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37378453
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Pathol Int Journal subject: PATOLOGIA Year: 2023 Document type: Article Affiliation country: Japan Country of publication: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Pathol Int Journal subject: PATOLOGIA Year: 2023 Document type: Article Affiliation country: Japan Country of publication: Australia